Search - tctmd.com

Displaying 341 - 360 of 2765

Sort: Relevancy | Date

News Daily News

Decades After WHI: Calcium, Vitamin D Linked to Different CVD, Cancer Outcomes

Caitlin E. Cox

March 12, 2024

News Conference News THT 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Michael O'Riordan

March 08, 2024

News Daily News

Patients With CKD Remain Underrepresented in Trials of CV Meds

Todd Neale

March 08, 2024

News Daily News

AHA Sums Up AI’s Potential in Cardiology, but Also the Hurdles Ahead

Yael L. Maxwell

March 07, 2024

News Daily News

How Meaningful Are Heart Failure Hospitalizations in Today’s RCTs?

Caitlin E. Cox

March 07, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

News Daily News

Semaglutide Winning Streak Continues in CKD With FLOW

Shelley Wood

March 06, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

News Daily News

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

Todd Neale

March 04, 2024

News Daily News

Real-life Patients Do Well With Intravascular Lithotripsy: Spanish Registry

Caitlin E. Cox

March 01, 2024

News Opinion CV Team Dispatch

March 2024 Dispatch for the CV Team

L.A. McKeown

March 01, 2024

News Daily News

High Lp(a) Levels Harmful in Patients With and Without ASCVD

Michael O'Riordan

February 27, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

Niacin, When Broken Down by the Body, Can Spur Inflammation

Caitlin E. Cox

February 22, 2024

News Daily News

Increased Lp(a) Ups CV Risk Regardless of hs-CRP Level

Yael L. Maxwell

February 15, 2024

News Daily News

Low Bleeding Profile With Asundexian Seen in Pooled Analysis

L.A. McKeown

February 13, 2024

News Daily News

CTO Diagnosed, Now What? European Experts Offer Advice on Revascularization

Caitlin E. Cox

February 09, 2024

News Conference News

Real-world Data Reiterate Value of CT-First Strategy to Rule Out Obstructive CAD

L.A. McKeown

February 02, 2024

News Daily News

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Michael O'Riordan

February 01, 2024

News Conference News ISET 2024

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

Caitlin E. Cox

January 31, 2024

Advertisement

Decades After WHI: Calcium, Vitamin D Linked to Different CVD, Cancer Outcomes

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Patients With CKD Remain Underrepresented in Trials of CV Meds

AHA Sums Up AI’s Potential in Cardiology, but Also the Hurdles Ahead

How Meaningful Are Heart Failure Hospitalizations in Today’s RCTs?

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Semaglutide Winning Streak Continues in CKD With FLOW

Debating the Role of T-TEER in the Sickest Patients

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

Real-life Patients Do Well With Intravascular Lithotripsy: Spanish Registry

March 2024 Dispatch for the CV Team

High Lp(a) Levels Harmful in Patients With and Without ASCVD

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Niacin, When Broken Down by the Body, Can Spur Inflammation

Increased Lp(a) Ups CV Risk Regardless of hs-CRP Level

Low Bleeding Profile With Asundexian Seen in Pooled Analysis

CTO Diagnosed, Now What? European Experts Offer Advice on Revascularization

Real-world Data Reiterate Value of CT-First Strategy to Rule Out Obstructive CAD

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content